
Dr. Georgia Tomaras is a tenured Professor of Surgery, Professor of Immunology, Professor of Molecular Genetics and Microbiology and is a Fellow of the American Academy of Microbiology (AAM) and a Fellow of the American Association for the Advancement of Science (AAAS). Dr. Tomaras is Co-Director of the Center for Human Systems Immunology (CHSI) Duke University and Director of the Duke Center for AIDS Research (CFAR). Her national and international leadership roles include: Executive Management Team (EMT) leader and mPI for the HIV Vaccine Trials Network (HVTN); Director of Lab Sciences (HVTN); and Chair of NIH Vaccine Research Center (VRC) Board of Scientific Counselors. Her prior leadership roles include serving as the Director of Research, Duke Human Vaccine Institute (DHVI); Director of the DHVI Training Program; Associate Director of DHVI Research; Co-Director of the Interdisciplinary Research Training Program in AIDS (IRTPA) Duke; Chair of the National Institutes of Health (NIH) AIDS Vaccine Research Subcommittee (AVRS), and Advisory Counsel member of the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID). Dr. Tomaras’ primary research focus is deciphering mechanisms of protective human immunity and identification of immune correlates of protection to further development of effective vaccines against infectious diseases.
Education and Training
- Postdoctoral Fellowship, Center For Aids Research, Department Of Surgery, Duke University, 1998 - 2001
- Ph.D., State University of New York Upstate Medical University, 1998
In the News
- Global List of Highly Cited Puts Duke in Top TenNovember 19, 2019
- Six From Duke Named Fellows of American Association for Advancement of ScienceNovember 27, 2018
- Duke Faculty Plentiful On ‘Highly Cited’ ListNovember 27, 2018
- Duke-Led Team Develops More Accurate Tool to Track New HIV InfectionsDecember 28, 2017
- Duke researchers develop more accurate guage of HIV infection incidenceDecember 21, 2017
- Past HIV Vaccine Trials Reveal New Path to SuccessMarch 20, 2014
- Duke Identifies Shortcomings In HIV VaccineMay 8, 2013
- Duke scientists find potent antibody to HIV-1February 23, 2009
Selected Grants
- Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ
- Interdisciplinary Research Training Program in AIDS
- Basic Immunology Training Program
- Viral Oncology Training Grant
- Advanced Immunobiology Traning Program for Surgeons
- Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTG)
- Quantitative Methods for HIV/AIDS Research
- New Analytic Approaches and Endpoints in Human HIV Vaccine Correlate Studies
- Bridging Antibody Fc-mediated Antiviral Functions Across Humans and Non-human Primates
- Nonhuman Primate Option 4
- A phase 2 randomized, open-label, parallel group study to assess the immunogenicity, safety, and tolerability of Moderna mRNA-1273 vaccine administered with casirivimab+imdevimab in healthy adult volunteers
- HVTN 705 Case Control Janssen
- GH-VAP: Duke Antibody Dynamics
- GH-VAP: Duke Antibody Dynamics Core Extension; INV-008612 Supplement
- CIVICS Component A - Option 2
- Duke Resident Physician-Scientist Program - NIAID
- Evidence2Practice: Leveraging implementation science to recruit HBCU/MSI students into careers in HIV research (CFAR CDEIPI Supplement)
- Sanofi Coronavirus Studies
- CoVPN 3008 Multi-Center, Randomized, Efficacy Study of Early vs Deferred Vaccination with COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
- HVTN Laboratory Center: Phase 1 PF
- HVTN Leadership and Operations Center (LOC)
- HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals
- HVTN TB Supplement
- HVTN 705 Pilot
- HVTN Laboratory Center: P5 PF
- HVTN Laboratory Center: 702 PF
- MGD020 IND enabling studies
- Bioinformatics and Computational Biology Training Program
- Immunologic control of HIV-1 through combination bNAbs and biologics
- Harnessing Mucin-IgG Interactions to Enhance HIV Vaccine Function
- Comparing HIV Mucosal Targets in US and Kenyan Populations
- Statistical methods for HIV-1 immune correlates studies
- HVTN 703
- Protocol Development Assays
- HVTN Scientific Leadership
- HVTN Laboratory Center: HVTN 704
- HVTN Laboratory Center: HVTN Phase 1
- HVTN Laboratory Center: HVTN 118
- PRO HIV-013 Humoral Immune Response
- HVTN TB Correlates Pilot Studies Supplement
- Defining universal protective signatures for HIV-1 through systems vaccinology
- QBI - reagent support quote
- HIV Research for Prevention 2018: Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P)
- HVTN Laboratory Center: HVTN 117
- HVTN Laboratory Center: HVTN 118
- HIV Vaccine Trials Network: LC P5 PF
- HVTN - A004
- Identifying key determinants that modulate maternal IgG transplacental transfer to the fetus
- Humoral and cellular immunity during acute HIV-1
- Nonhuman Primate Core-Option 6
- The duality of vaccine elicited HIV specific-IgA antibodies: Providing protection or diminishing protection
- HVTN 117
- Early Infection Response
- Animal Models of Infectious Diseases Part A
- Statistical methods for HIV-1 immune correlates studies
- HIV Vaccine Trials Network: LC P5 PF
- HVTN 505 Protocol
- HVTN LC: Virion Capture
- LC: HIV Vaccine Trials Network: Phase 1 PF
- McElrath Objective 3-Evaluate potential mucosal quality indicators
- HIV Envelope-specific functional antibody responses in HIV-exposed, HIV-vaccinated infants
- Harnessing Antibody-Mucus Interaction to Prevent HIV Transmission
- Education - Training
- HIV-1 Gene Suppression by CD8+ T Cells
- Testing the ability of antibody-mucin interactions to provide vaccine function
- Epigenetic Control of the CD8+ T-cell Response to HIV
- McElrath Objective 3-Evaluate potential mucosal quality indicators
- AIDS International Training and Research Program
- Non-human Primate Binding Antibody Evaluation
- Large Scale Antibody and TCell Epitope Discovery
- Elucidation of the Mechanisms of CD8+ T Cell Noncytolytic Antiviral Response
- Central Laboratory for the HIV Vaccines Trial Network
- NCRR FACSAria Cell Sorter